Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Biora in-licenses new protein for dental applications

Dec. 17, 1997

Alteon prepares new AGE inhibitors

Dec. 9, 1997

rhBMP-2 efficacy in dental reconstruction demonstrated

Nov. 26, 1997

Emdogain now available in Switzerland and Austria

Oct. 23, 1997

Alpharma will distribute PerioGlas in key European markets

Oct. 20, 1997

Atrix seeks U.K. approval for Atridox

Oct. 15, 1997

Periodontal tissue monitor kit launched in U.S.

Oct. 9, 1997

rhBMP-2 promotes periodontal wound healing in rodent model

Sep. 22, 1997

Block Drug to market Atridox in Canada

Sep. 16, 1997

Seven studies published on Emdogain

Aug. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...